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ABSTRACT We compared cetylpyridinium chloride (CPC), ethanol (ETOH), and
OMNIgene.SPUTUM (OMNI) for 28-day storage of sputum at ambient temperature
before molecular tuberculosis diagnostics. Three sputum samples were collected
from each of 133 smear-positive tuberculosis (TB) patients (399 sputum samples).
Each patient’s sputum was stored with either CPC, ETOH, or OMNI for 28 days at am-
bient temperature, with subsequent rpoB ampliﬁcation targeting a short fragment
(81 bp, GeneXpert MTB/RIF [Xpert]) or a long fragment (1,764 bp, in-house nested
PCR). For 36 patients, Xpert was also performed at baseline on all 108 fresh sputum
samples. After the 28-day storage (D28), Xpert positivity did not signiﬁcantly differ
between storage methods. In contrast, higher positivity for rpoB nested PCR was ob-
tained with OMNI (n  125, 94%) than with ETOH (n  114, 85.7%; P  0.001).
Smears with scanty acid-fast bacilli (AFB) had lower rpoB PCR positivity with ETOH
storage (n  10, 41.7%) than with CPC (n  16, 66.7%; difference, 25%; 95% conﬁ-
dence interval [CI], 3.5 to 46.5; P  0.031) or OMNI (n  16, 69.6%; difference,
26.1%; 95% CI, 3.8 to 48.4; P  0.031), with no difference between CPC and OMNI.
Poststorage, the threshold cycle (CT) values signiﬁcantly decreased compared to
those prestorage with ETOH (difference, 1.1; 95% CI, 1.6 to 0.6; P  0.0001)
but not with CPC (P  0.915) or OMNI (P  0.33). For one patient’s ETOH- and CPC-
stored specimens with a CT of 10, Xpert gave results of rifampin false resistant at
D28, which was resolved by repeating Xpert on a 1/100 diluted specimen. In conclu-
sion, 28-day storage of sputum in OMNI, CPC, or ETOH at ambient temperature does
not impact short-fragment PCR (Xpert), including for low smear grades. However, for
long-fragment PCR, ETOH yielded a lower PCR positivity for low smear grades, while
the performance of OMNI and CPC was excellent for all smear grades. (The study
has been registered at ClinicalTrials.gov under registration number NCT02744469.)
KEYWORDS AFB scanty, OMNIgene.SPUTUM, Xpert, cetylpyridinium chloride,
ethanol, isolate, molecular tests, short/long-fragment PCR, sputum, storage
Molecular tuberculosis (TB) diagnostics are more sensitive than microscopy andfaster than culture. In addition to the detection of TB, molecular analyses can
provide the drug resistance proﬁle of the affecting Mycobacterium tuberculosis complex
(MTBC) strain(s) and strain typing for diversity studies. In low-income countries, mo-
lecular analyses may not be available in peripheral laboratories, and specimens need to
be shipped to remote intermediate or central reference laboratories. Logistic con-
straints can delay the time between specimen collection and analysis, potentially
negatively impacting the results.
Sample deterioration can be overcome by the use of sputum preservation reagents,
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such as ethanol (ETOH) (1) and cetylpyridinium chloride (CPC), already widely used, or
a proprietary buffer such as OMNIgene.SPUTUM (OMNI; DNA Genotek, Ottawa, Canada)
(2, 3). ETOH preservation allows for molecular analyses only, as it inactivates TB bacilli
(1), while CPC and OMNI preservation can precede both molecular analyses and culture
(2, 3). ETOH-preserved samples no longer constitute a biosafety risk, hence do not
require a speciﬁc containment laboratory level, and can be shipped with minimal
restrictions. ETOH is less expensive than CPC, which in turn is less expensive than OMNI.
No limit has been speciﬁed for specimen preservation in ETOH and CPC, while for
OMNI, storage for a maximum of 8 days is speciﬁed by the manufacturer. The time
between specimen collection and analysis can vary widely depending on shipping
logistics and distance, the urgency of the molecular analysis to be performed, and
whether specimens are assembled for batch processing. A recent systematic review
highlighted the lack of evidence on the performance of commercial storage reagents
to preserve sputum samples, especially paucibacillary samples, which is of great
diagnostic importance (4, 5).
Molecular methods for the detection of rifampin (RIF), for example, vary by platform
and target length, ranging from the 81-bp rifampin resistance-determining region
(RRDR) target of the rpoB gene covered in GeneXpert MTB/RIF (Xpert; Cepheid, Sunny-
vale, CA, USA) (6) to the 1,764-bp target of the rpoB gene that also covers resistance-
conferring mutations positioned outside the RRDR (7).
We compared ETOH, CPC, and OMNI for 1-month (28-day) storage of smear-positive
sputa at ambient temperature, with subsequent automated Xpert and conventional
gel-based rpoB nested PCR, including paucibacillary specimens.
MATERIALS AND METHODS
Ethics considerations. This evaluation was embedded in the BeniDiT study that was approved by
the national ethics committee of Benin and the ethics committees of the Institute of Tropical Medicine
(ITM) of Antwerp and the University of Antwerp in Belgium. The study was registered at ClinicalTrials.gov
under registration number NCT02744469. Before inclusion, all the study participants provided written
informed consent. Participants’ specimens were pseudonymized before laboratory analyses.
Study design, participants, and specimens. The main study design and specimen workﬂow are
summarized in Fig. 1. In total, 399 sputum samples were collected from 133 consecutive new smear-
positive TB patients who were prospectively recruited among patients registered for TB screening in the
National University Hospital for TB and Lung Diseases in Cotonou, Benin (Centre National Universitaire
Hospitalier de Pneumo-Phtisiologie [CNHU-PPC]) during a 3-month period. The sputa were collected
before patients started anti-TB treatment. Laboratory analyses were performed in the supranational
reference laboratory for mycobacteria in Cotonou, Benin (Laboratoire de Référence des Mycobactéries
[LRM]), located in the CNHU-PPC.
In total, three pretreatment sputum samples (spot day 1, morning, and spot day 2) were collected
from each participating patient. TB conﬁrmation, per national guidelines (8), was based on smear
microscopy on unprocessed sputa using the WHO/IUATLD acid-fast bacillus (AFB) grading scale for
ﬂuorescence microscopy (9). Each sputum sample was stored with either an equal volume of ETOH (ﬁnal
concentration 50%), CPC 1% (ﬁnal 0.5%), or OMNI (ﬁnal 50%) (1, 3). The 1% CPC solution was prepared
by dissolving the necessary amount of CPC in a 2% sodium chloride solution. The sequence of the
sputum samples (spot day 1, morning, and spot day 2) assigned to a speciﬁc storage reagent alternated
weekly. The sputum mixtures were vortexed and stored at ambient temperature for 28 days, after which
they were centrifuged at 3,800 g (3) for 20 min at 28°C, the supernatant was discarded, and the pellet
was resuspended in sterile distilled water (of equal volume to the initial unprocessed sputum). At least
1 ml of the suspension was used for Xpert and 200 l was extracted for rpoB nested PCR. For 36 patients
(108 sputum samples) who produced large-volume samples (at least 2.5 ml per sputum container), the
Xpert analysis was also performed at baseline before storage of the sputum in the storage reagent. The
ambient temperature of the storage room was recorded every day; no temperature control measures
such as air conditioning were in place.
Prior to the main study, at the Institute of Tropical Medicine in Antwerp (ITM), the reference M.
tuberculosis isolate H37Rv (dilution 103 McFarland 1) was also stored in ETOH, CPC, and OMNI, in
triplicates, for 37 days at ambient temperature and 37°C and tested with Xpert to check whether the
detectable bacillary load would be affected. As the ITM laboratory is air conditioned (20°C to 25°C) and
Belgium has a moderate climate, the standard set temperature of the incubator (37°C) was used to mimic
higher temperature conditions encountered in many countries of high endemicity. To mimic delayed
intercontinental shipments, such as those potentially facing customs clearance issues, the storage time
was extended to 37 days.
Molecular analyses. Xpert MTB/RIF is an automated system with DNA extraction and ampliﬁcation
integrated for the real-time quantitative PCR (qPCR) of ﬁve probes (A, B, C, D, and E) covering the RRDR
of the rpoB gene. Resistance to RIF is detected through absence or delayed reaction with one or more
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probes (6). The assay was used as per the manufacturer’s instructions (6). For the fresh sputum (when
baseline Xpert was performed before storage) or for the suspension after storage, one volume of the
specimen (suspension-sputum) was mixed with 2 volumes of the Xpert “sample reagent” as recom-
mended by the manufacturer for sputum, to ensure the comparability of fresh sputum and respective
suspension after storage. Poststorage threshold cycle (CT) values were compared across storage methods
and to CT values from fresh sputum when available. To ensure valid comparisons, specimens and Xpert
sample reagent volumes were measured with graduated pipets.
In-house rpoB nested PCR. Sediments from CPC- and OMNI-stored specimens were inactivated at
95°C for 10 min (10). After a digestion of 200 l of the suspension with proteinase K, DNA was extracted
using the semiautomated Maxwell 16 tissue DNA puriﬁcation kit (AS1030) with a Maxwell machine
(model 4.9; Promega) and eluted in 300 l Maxwell elution buffer as previously described (11, 12). rpoB
nested PCR was performed as previously described (7). Positive and negative extraction as well as
ampliﬁcation controls were included. The positive extraction control was a sediment from a sputum
known as MTBC PCR positive. The positive ampliﬁcation controls consisted of DNA extracts from H37Rv
suspensions (102, 103, and 104 of McFarland 1) and DNA extracts (102 and 104 g/l) from MTBC
PCR-positive sputum. The negative extraction control consisted of molecular-grade water processed as
other sputum specimens in each DNA extraction run. The negative ampliﬁcation control consisted of
molecular-grade water (for both 1st PCR run to nested run and nested run separately) processed as a
specimen DNA extract along with DNA extracts from sputum. All specimens (ETOH, CPC, and OMNI) from
a patient were processed in the same extraction run or PCR run. For the conventional PCR, specimens
were coded so that the person reading the gel was blinded to the patient’s identiﬁcation (ID) or storage
method assigned. To check for possible PCR inhibition, the rpoB nested PCR was repeated for specimens
with a negative result using a one-tenth dilution of the original DNA extract.
Statistical analyses. Statistical data analysis was performed using Stata 12.0 (StataCorp, USA). We
used McNemar’s chi-square test to compare paired categorical data across ETOH, CPC, and OMNI groups
FIG 1 Flow diagram for specimens and methods.
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and paired t test to compare CT values. The difference (Diff) in proportion or mean difference was
calculated with a 95% conﬁdence interval (CI) and P value, which was considered signiﬁcant at 0.05.
RESULTS
The sputa stored in the respective reagents had similar AFB positivity grades (see
Table S1 in the supplemental material). In the room where sputum mixtures with
storage reagent were stored, the temperature ranged from 26°C to 31.9°C, with an
average of 28.5°C and a median of 28.4°C. All included negative controls remained
negative by nested PCR.
After the 28 days of storage (D28), the presence of MTBC was conﬁrmed by Xpert in
132 (99.2%) patients. Xpert yielded a positive result for most sputa (98.5%, 99.2%, and
99.2% for ETOH, CPC, and OMNI, respectively), and the Xpert positivity across storage
methods did not signiﬁcantly differ (Table 1). After stratiﬁcation by AFB smear grading,
all but three AFB-scanty sputum samples (2 stored with ETOH, 1 stored with CPC) and
a 1 AFB-positive sputum (stored with OMNI) were Xpert positive (see Table S2).
However, also for scanty specimens, positivity was not signiﬁcantly different across
storage methods for Xpert (Table S2).
In contrast, higher positivity for rpoB nested PCR was obtained with OMNI storage
(94%), which differed signiﬁcantly between OMNI and ETOH (P  0.001) (Table 1). Most
negative nested PCRs occurred among AFB-scanty sputa (14/24 for ETOH, 9/25 for CPC,
and 7/24 for OMNI) (Table 2). Lower rpoB PCR positivity among AFB-scanty sputa was
found with ETOH storage than with either CPC (Diff, 25%; 95% conﬁdence interval [CI],
3.5 to 46.5; P 0.031) or OMNI (Diff, 26.1%; 95% CI, 3.8 to 48.4; P 0.031), whereas CPC
and OMNI storage yields were similar (P  1) (Table 2; see also Table S3). For 1
AFB-positive sputa, the differences between ETOH, CPC, and OMNI were not signiﬁcant
(Table S3).
In total, sputa from two patients tested RIF resistant in Xpert, with probes A or E
absent. Hence, we compared CT values of probe B and D to assess CT value variability
TABLE 1 Positivity of PCR by storage method
Storage
Xpert MTB/RIF at D28 rpoB PCR at D28
No. (%) positive Total no. Diff (95% CI)a P valueb No. (%) positive Total no. Diff (95% CI)a P valueb
ETOH-28 131c (98.5) 133 114e (85.7) 133
CPC-28 132 (99.2) 133 0.8 (1.5 to 3) A 1 121e (91) 133 5.3 (1.1 to 11.7) A 0.119
OMNI-28 132d (99.2) 133 0.8 (1.5 to 3) B 1 125e (94) 133 8.3 (2.8 to 13.7) B 0.001
OMNI-28 vs CPC-28 0 (0.8 to 0.8) C 1 3 (1.9 to 7.9) C 0.289
Total 395 (99) 399 360 (90.2) 399
aUppercase letters indicate comparisons for statistical testing. A, CPC-28 versus ETOH-28; B, OMNI-28 versus ETOH-28; C, OMNI-28 versus CPC-28.
bP values were calculated using McNemar’s exact test.
cIncludes 2 errors that became positive (high) after testing 1/10 dilution of the sediment.
dIncludes 1 invalid that became positive (very low) after testing 1/10 dilution of the sediment.
eFor all PCR-negative specimens, including a set of specimens with discrepant PCR results from the same patient, the rpoB PCR was repeated on a 1/10 dilution of the
DNA extract. All remained negative, but one stored in OMNI became positive.
TABLE 2 Positivity of rpoB PCR by sputum AFB grade
Sputum AFB gradea
rpoB PCR results for specimens stored in:
ETOH CPC OMNI
No. (%) positive Total no. No. (%) positive Total no. No. (%) positive Total no.
3 positive 13 (100) 13 16 (100) 16 15 (100) 15
2 positive 63 (96.9) 65 63 (98.4) 64 68 (100) 68
1 positive 28 (90.3) 31 26 (92.9) 28 25 (96.2) 26
Scantyb 10 (41.7) 24 16 (64) 25 17 (70.8) 24
Total 114 133 121 133 125 133
aUIATLD/WHO scale for ﬂuorescence microscopy (9) using original (fresh unprocessed) sputum.
bAmong smear-scanty specimens, Xpert positivity was signiﬁcantly different for CPC versus ETOH (McNemar’s exact test, P  0.31) and OMNI versus ETOH (P  0.31)
but similar for OMNI versus CPC (P  1) (see Table S3 in the supplemental material).
Sanoussi et al. Journal of Clinical Microbiology










across storage methods. The mean CT values for probe D after 28-day storage were 17
for ETOH, 17.9 for CPC, and 18.1 for OMNI. The probe D CT values after ETOH storage
were signiﬁcantly lower (more MTBC DNA ampliﬁed) than those observed either after
CPC storage (CPC versus ETOH, P 0.00001) or after OMNI storage (OMNI versus ETOH,
P  0.00001) but did not signiﬁcantly differ between OMNI and CPC storage (P  0.51)
(Table 3). Likewise, for probe B, CT values were signiﬁcantly lower for ETOH than CPC or
OMNI storage, but no difference was observed for OMNI versus CPC (data not shown).
As a sensitivity analysis, for 36 patients (108 sputum samples) for whom Xpert was
also performed on fresh sputum, we compared CT values for three fresh unprocessed
(D0) and three poststorage (D28) sputum samples across storage methods. No signif-
icant difference in D0 CT values was observed between the sputa assigned to either
ETOH, CPC, or OMNI storage (mean D0 CTs for probe D, 18.6 for ETOH versus 18.4 for
CPC versus 18.1 for OMNI; nonsigniﬁcant for all comparisons), showing that groups of
sputa assigned to each of the three storage methods were comparable in terms of fresh
bacillary load before mixing with storage reagents. However, overall D28 CT values
compared across storage methods were signiﬁcantly lower for ETOH than for CPC or
OMNI yet not different for OMNI versus CPC (mean D28 CTs for probe D, 17.5 for ETOH
versus 18.3 for CPC versus 18.8 for OMNI, with P(CPC-ETOH)  0.015; P(OMNI-ETOH)  0.005;
P(OMNI-CPC)  0.31). This conﬁrmed the ﬁndings on all sputa that ETOH preservation,
unlike CPC or OMNI, lowers Xpert CT values. Despite the fact that the quantiﬁcation of
the bacterial load by sputum AFB microscopy is less precise than by Xpert CT value,
ETOH storage also yielded more Xpert “high” bacillary loads among AFB weakly
positive (1 positive and scanty) sputa (25.5% versus 11.3% for CPC and 6% for
OMNI) (Table S2).
Likewise, a direct comparison of CT values from baseline and stored sputum from the
same patient (CT(stored [D28])  CT(fresh [D0])) signiﬁcantly decreased (more detectable
DNA) after storage in ETOH (1.1; 95% CI, 1.6 to 0.6; P  0.0001 for probe D),
whereas it did not differ after storage in CPC (P  0.915, probe D) or OMNI (P  0.33,
probe D) (Table 4 for probe D; see Table S4 for probe B).
For one patient, all three baseline sputum samples (D0) were RIF sensitive by Xpert.
At D28, the ETOH-stored specimen turned RIF resistant, while CPC- and OMNI-stored
sputa remained RIF sensitive. After repeat testing of the three D28 specimens by Xpert,
RIF resistance was conﬁrmed for the ETOH specimen (probe A and E missing, CT of 8.7
for probe D) and the CPC specimen (only probe A missing, CT of 8.7 for probe D), while
the OMNI specimen remained RIF sensitive (CT of 11.5 for probe D). As the Xpert CT
values were low, we repeated Xpert on a 1/100 dilution of the D28 suspensions, and all
were RIF sensitive. RIF sensitivity was further conﬁrmed by testing the undiluted
suspensions with Xpert Ultra (Cepheid, Sunnyvale, CA, USA) and DNA sequencing of the
rpoB nested PCR amplicons (wild-type rpoB).
Regarding the H37Rv bacterial suspensions, the Xpert positivity was the same
(“medium”) for CPC and OMNI at either ambient temperature or 37°C, yet for ETOH, the
TABLE 3 Change in Xpert CT values for probe D after 28-day storage across storage
methods
Storage methoda Total no.
Xpert D28 probe D CT values P valueb
Mean (95% CI) Diff (95% CI) Diff 0 Ha: Diff> 0
ETOH-28 131 17.0 (16.3–17)
CPC-28 131 17.9 (17.2–18) 0.9 (0.5 to 1.3) 0.00001 0.00001
ETOH-28 130 17.0 (16.4–17.7)
OMNI-28 130 18.1 (17.4–18.8) 1.1 (0.6 to 1.6) 0.00001 0.00001
CPC-28 131 18 (17.3–18.7)
OMNI-28 131 18.2 (17.5–18.8) 0.2 (0.3 to 0.7) 0.51 0.253
aETOH-28, storage in ETOH for 28 days; CPC-28, storage in CPC for 28 days; OMNI-28, storage in OMNI for
28 days.
bP values were calculated using paired t tests; only paired sputa (i.e., sputa from the same patient) with
positive Xpert (i.e., CT  0) for the 2 compared storage methods were included. Ha, alternative hypothesis
for the statistical analysis.
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results were temperature dependent, remaining “medium” at ambient temperature but
decreasing (“low”) at 37°C in two replicates.
DISCUSSION
ETOH, CPC, and OMNI storage for 28 days did not yield signiﬁcant differences in the
proportions that tested Xpert positive, whereas successful ampliﬁcation of a large rpoB
target was signiﬁcantly more likely after OMNI storage (94%) than after ETOH storage
(85.7%), without signiﬁcant difference with CPC (91%). Of concern, one sample tested
false RIF resistant after 28-day storage in ETOH and CPC, likely related to the lowered
CT values after storage, below the range for optimal detection of rifampin resistance.
Thus, for all sputa—whether fresh or stored—in the context of CT values of 10, a RIF
resistant result should be conﬁrmed by dilution (1/100) of the remaining sample or a
new sample if there are none left over. Studies similar to this could be conducted on
Xpert Ultra as this becomes the standard Xpert MTB/RIF testing (13).
Other authors comparing shorter storage durations (2 to 21 days) also found com-
parable Xpert positivity after storage in CPC (98.9% versus 99.2% in our study) or OMNI
(97.9% [14] and 95% [15] versus 99.2% in our study).
The yields of a long rpoB fragment from AFB-scanty sputa were signiﬁcantly higher
for OMNI and CPC storage than for ETOH storage. On the contrary, Xpert CT values after
the 28-day storage were signiﬁcantly lower in ETOH-stored sputa than those stored in
CPC or OMNI, despite comparable CT values in fresh sputa at baseline. Similarly,
Asandem et al. found that OMNI yielded less Xpert “high” bacillary load (after 7 days of
storage) versus that in freshly decontaminated sediments (decrease of 6%) (14). The
differences observed for ETOH storage, with lower yields for long-fragment PCR yet
higher bacterial loads detected in Xpert than with CPC and OMNI, are unlikely to be
explained by a lower compatibility of ETOH with Maxwell DNA extraction, as ETOH
enhances/facilitates DNA extraction (as also shown by Rabodoarivelo et al. [16]) by
destroying the protein structure of the bacterial cell surface (17). This was conﬁrmed by
the lowered CT at D28 for EtOH samples in our study. Furthermore, the storage reagent
mixed with the sputum was discarded after the poststorage centrifugation, before the
pellet was resuspended in sterile distilled water, thus limiting the interaction between
storage and extraction reagents. Also, such interaction between ETOH and proteinase
K in lysing buffer (pH 7.5) used prior to our modiﬁed Maxwell extraction is unlikely (11,
18). In addition, ETOH is a component of the Maxwell extraction cartridge (security
datasheet [12]). The more plausible explanation is the fragmentation/degradation of
the DNA, as ETOH creates a disordered state in the bacterial DNA by cross-linking the
bases so that the DNA strands can no longer properly separate, interfering with
replication and transcription (17). Therefore, the initial denaturation step of the PCR
process might cause fragmentation of the bacterial DNA, which no longer properly
TABLE 4 Change in CT values for Xpert probe D from storage at D0 to processing at D28
Storagea Total no. of specimens
Probe D CT values P valueb
Mean (95% CI) Diff (95%CI) Ha: Diff< 0 Diff 0
ETOH
D0 36 18.6 (17.3–19.9)
D28 36 17.5 (16.1–19) 1.1 (1.6 to 0.6) 0.0001 0.0002
CPC
D0 36 18.4 (17–19.8)
D28 36 18.3 (16.8–19.9) 0.03 (0.7 to 0.5) 0.457 0.915
OMNI
D0 35c 18.1 (16.8–19.4)
D28 35c 18.3 (17–19.7) 0.2 (0.3 to 0.7) 0.835 0.330
aD0, day 0 (baseline before storage with a storage reagent); D28, after 28-day storage with a storage reagent.
bP values were calculated using paired t tests. Ha, alternative hypothesis for the statistical analysis.
cOne sputum excluded from that CT difference analysis on OMNI, as the AFB-positive sputum (of the 3 AFB-scanty sputa of a patient) randomly assigned to OMNI had
a negative D0 Xpert.
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separates, as result of the ETOH effect. This could affect the recovery/ampliﬁcation of
the bacterial DNA, which is more perceivable in a long-fragment target (1,764 bp in
rpoB PCR versus 81 bp in Xpert), especially in paucibacillary samples. Likewise, NaOH-
induced changes in the bacterial DNA sequences of paucibacillary samples after
prolonged storage in Xpert sample reagent risk causing false resistant results (19).
Furthermore, the impact of ETOH storage might be temperature dependent, as evi-
denced by data of the H37Rv isolate with decreased positivity at 37°C. This needs to be
further investigated, as we only tested one strain, albeit in triplicates, and our sputum
samples were not exposed to temperatures above 32°C.
Storage of sputum in 50% (used in this study) or 70% ETOH ﬁnal concentration (used
in some laboratories) renders the TB bacilli nonviable after 1 h of storage (1; unpub-
lished data from our laboratory [ITM]). PCR results for a 123-bp fragment were similar
for both ETOH concentrations after 1 day of storage (1). The long-fragment rpoB PCR
after 1-h storage of 4 triplicates of isolate-spiked sputa yielded 12 positive results in
50% ETOH versus 11 in 70% ETOH and, after 14-days storage, 10 versus 11 positives,
respectively (unpublished data from ITM). In other unpublished data from ITM, analyses
of 943 sputa after long-term (20 to 218 days) storage in 70% ETOH at noncontrolled
“ambient” temperature in Bangladesh showed a similar positivity in rpoB nested PCR for
3, 2, and 1 AFB-grade sputa (96%, 95%, and 90% versus 100%, 96.9%, and 90.3%,
respectively, in the current study). In contrast, positivity among AFB-scanty sputa was
lower in the present study (41.7%) than in the unpublished data (77%). Van Deun et al.
found that sputa stored in 70% ETOH for a period ranging from 2 to 7 years yielded an
overall positivity of 94% in the long-fragment rpoB nested PCR versus 85.7% for 50%
ETOH in this study (20).
A strength of this study is the paired design, with comparable bacterial loads by AFB
smear-positivity grading and Xpert CT values between all groups. As a limitation,
ambient temperatures vary, potentially affecting the generalizability of our ﬁndings to
hotter climates, and we did not test long-term storage without additives, which may be
challenging because of potential overgrowth by other organisms. Smear-negative
sputa from TB patients were not included in this study, with likely further decreased
yield of rpoB ampliﬁcation in all storage solutions. Moreover, we did not test the
compatibility of different storage solutions with other DNA extraction methods other
than the Maxwell method. The use of basic extraction methods consisting of boiling
sputum (such as the Chelex method) resulted in good yield after storage of sputum in
ETOH (16). We centrifuged and discarded the storage reagent from sputa before testing
(as recommended for OMNI [3]) to avoid eventual reagent interaction, which is unlikely
for ETOH and unknown for CPC and OMNI. This may not be feasible in Xpert centers
without centrifuges. We centrifuged stored sputa at 3,800  g, the upper range (3,000
to 3,800  g) recommended for OMNI by its manufacturer (3) and compatible with
other TB analyses (3,000  g recommended [9]). At 3,000  g but not 3,800  g, we
noted that the OMNI pellet tended to slip and be discarded with supernatant after
centrifugation.
As summarized in Fig. 2, in conclusion, the overall performance of ETOH, CPC, and
OMNI for 28-day storage of sputum at ambient temperature is excellent, especially for
subsequent Xpert analysis and long-fragment PCR of non-scanty AFB-positive samples.
It is advisable to use ETOH for subsequent short-fragment PCR (Xpert) when culture is
not needed and to use either CPC or OMNI when culture is needed. For paucibacillary
sputa, OMNI or CPC will have better yields for subsequent long-fragment PCR. When
culture is needed, the choice between OMNI and CPC, which are equally performant for
either subsequent short-fragment PCR (Xpert) or long-fragment (conventional) PCR,
should be based on their cost (OMNI is57more expensive than CPC [$1.15 versus
$0.02/ml of sputum] [5]) and their performance for culture after 28-day storage (CPC
followed by a short decontamination is better than OMNI for culture on Lowenstein-
Jensen medium [21]). The choice should be also based on the culture medium to be
used. There is a reduced/delayed growth in mycobacterial growth indicator tubes
(MGITs) after OMNI (2, 22, 23). Likewise, direct inoculation of CPC-preserved specimens
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is not compatible with MGITs (24), with a reduced/delayed positivity (25); however,
washing off the CPC prior to inoculation in MGITs (2, 21, 25) increases the culture
positivity rate (25), a procedure not yet common in routine practice. One should also
take into account whether poststorage ﬂuorescence microscopy-based tests will be
realized (CPC is not compatible with ﬂuorescence microscopy [2]), the constraints
regarding import or transport of dangerous products (CPC), the availability of a
centrifuge adjustable to ambient temperature (CPC crystalizes at cold temperatures [9]),
and the availability of a centrifuge reaching 3,800 g (needed for OMNI). CPC and
OMNI are likely more stable than ETOH for the storage of specimens/cultures at high
ambient temperature (37°C) and possibly beyond.
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